Three Years Out: Long COVID and the Mental Health Reckoning

A neighbor of mine recovered from COVID in early 2022. At least, that's what everyone thought. The fever broke, the congestion cleared, and she went back to work. What didn't go away — what she spent the next two and a half years trying to explain to everyone around her, including her doctors — was the fog. The flat affect on mornings that should have been fine. The way a full night of sleep left her feeling like she'd been awake for two days.

She isn't alone in ways that are now documented rather than anecdotal. A 2026 follow-up study covered by CIDRAP found that three years after infection, 8.8% of long-COVID respondents were still reporting depressive symptoms and 10.4% were reporting anxiety symptoms. A parallel review in Nature Reviews Neurology traced the neurological mechanisms behind these numbers — the disrupted cytokine signaling, the neuroinflammation, the ways a viral infection can leave lasting marks on the brain's chemistry long after the virus is gone.

Three years out, this is still unfinished business.

How a Virus Can Change Your Mood

The brain and the immune system are not separate systems that occasionally send each other memos. They are continuous and deeply intertwined. When the body mounts an inflammatory response — as it does during any serious infection — that response crosses into the central nervous system.

Cytokines, the small proteins that coordinate immune response, can pass the blood-brain barrier and alter neurotransmitter production. Specifically, inflammatory cytokines are associated with reduced serotonin availability, reduced dopamine signaling, and disrupted glutamate metabolism. These are not subtle effects; they are the same mechanisms implicated in major depressive disorder.

In long-COVID specifically, there appears to be a pattern of sustained neuroinflammation in some patients — a low-grade immune activation that doesn't fully resolve. The SARS-CoV-2 virus can infect cells lining the blood-brain barrier. Microglial cells — the brain's resident immune cells — can remain activated in ways that disrupt normal neural function for months or years after the initial infection.

This is not a psychological explanation in the dismissive sense. It is brain biology. The mood changes and cognitive symptoms that long-haulers report have measurable correlates in neural tissue. They are not secondary to the "stress of being sick." They are physiological consequences of the infection itself.

The Years When No One Believed Them

Understanding this matters partly because of what long-haulers went through — and in many cases are still going through — when they tried to explain their symptoms.

The medical system is structurally oriented toward conditions it can measure with standard tools. If the MRI is clear, if the bloodwork is in range, if the routine markers don't show anything, the implicit message — however unintentionally communicated — is that the problem is psychological in the pejorative sense: it's in your head meaning not real, rather than located in your brain tissue.

Long-haulers reported this repeatedly. Being told they were anxious, or deconditioned, or overconcerned. Being pushed toward early return to work or activity when their bodies couldn't sustain it. Experiencing what researchers have now started calling medical invalidation — not malicious but systematic, because the tools for measuring neuroinflammation or cytokine profiles weren't being deployed in routine primary care settings.

This had downstream consequences. The experience of not being believed intensifies psychological distress. Anxiety and depression that might have been manageable became compounded by the secondary wound of having to constantly prove that what you were experiencing was real. Post-exertional malaise — the specific phenomenon where activity worsens symptoms rather than improving them — was dismissed as deconditioning and treated with protocols that made people worse.

We understand more now. The understanding came late, but it came.

When Fatigue and Depression Overlap

One of the genuinely difficult clinical challenges in long-COVID mental health is disentangling fatigue from depression. The overlap is substantial: both involve low energy, difficulty concentrating, disrupted sleep, and reduced motivation. Both respond poorly to the advice to "just push through."

But they're not the same, and treating fatigue like depression — or depression like fatigue — leads to the wrong interventions.

Long-COVID fatigue, particularly the type associated with post-exertional malaise (PEM), is distinct in one critical way: it worsens with exertion in ways that ordinary fatigue does not. A person with ordinary fatigue or standard depression usually does feel somewhat better after moderate activity. A person with PEM often doesn't — their symptoms can substantially worsen following even gentle activity, and the crash can last days.

This distinction matters because the standard behavioral approach to depression includes graded activity — gently increasing exercise over time. Applied to PEM, this approach can cause real harm. The evidence now suggests that for long-haulers with PEM, the priority is energy management and pacing first, with any increase in activity designed carefully around the individual's symptom response rather than a preset schedule.

Depression, as a secondary consequence of the illness, the isolation, and the medical invalidation, also needs to be addressed — but through approaches that fit its actual origin.

What the Evidence Says About Treatment

This is an area where the evidence is still accumulating and appropriate humility is warranted. But several approaches have accrued enough support to be worth knowing about:

Cognitive pacing and energy management. Learning to stay within one's "energy envelope" — avoiding the push-crash cycle — is consistently described as helpful by long-haulers and is supported by the ME/CFS literature, which overlaps significantly with long-COVID. This isn't giving up; it's a strategic approach to preserving function and creating conditions for recovery rather than repeatedly crashing back to baseline.

Low-dose naltrexone (LDN). Several small trials have shown promising results for LDN in long-COVID and ME/CFS, particularly for neuroinflammation and fatigue. The mechanism is thought to involve microglial modulation — reducing overactivation of the brain's immune cells. The evidence base is still developing, and it's an off-label use, but it's one of the more interesting treatment candidates currently in trials.

Graduated exercise, very carefully implemented. For long-haulers without significant PEM, gentle movement can be helpful. "Graduated" means genuinely graduated — based on symptom response, not a standard rehabilitation protocol. Many long-COVID clinics have developed individualized approaches that look quite different from conventional exercise prescriptions.

Treating secondary depression on its own terms. For long-haulers dealing with depression — and many are — standard approaches remain relevant: therapy, medication where indicated, social support. The neuroinflammatory component may eventually be addressed with anti-inflammatory approaches, but the psychological and social dimensions of prolonged illness also respond to conventional care and shouldn't wait.

When Someone You Know Didn't Bounce Back

If you have a partner, a friend, or a family member who got COVID and hasn't fully recovered — mentally, cognitively, or emotionally — there are things that help and things that don't.

The most damaging thing, consistently, is skepticism about the reality of what they're experiencing. Not because they need unconditional validation for everything, but because the effort of proving one's illness is exhausting and demoralizing in ways that genuinely worsen it. Believing them costs you very little. Disbelieving them costs them a great deal.

Second: don't orient everything toward "getting back to normal." For some people, some of what was normal won't come back quickly, and pushing that frame — even from love — adds pressure that makes recovery harder, not easier. The more useful question is: what does a good day look like now, and how do we create more of those?

Practical help matters more than sympathy in most cases. Meals on hard days, rides to appointments, being the person who looks up the nearest long-COVID clinic and handles the referral paperwork — these are concrete contributions that reduce the cognitive load on someone whose cognitive resources are limited.

And finally: be a steady presence without catastrophizing the bad days or prematurely celebrating the good ones. Long-COVID tends to be nonlinear — better weeks followed by setbacks. Showing up consistently, without drama in either direction, is more sustaining than any particular gesture.

The three-year mark was supposed to feel like an endpoint. For many people, it doesn't. The counting isn't finished.

FAQ

What's the difference between long COVID and post-COVID depression?

Long COVID is a broad umbrella for symptoms persisting after acute infection — fatigue, cognitive difficulties, physical symptoms. Post-COVID depression is one component: it may result from neuroinflammation affecting mood regulation, or from the psychological response to prolonged illness and isolation, or both. They often co-occur and aren't cleanly separable; useful treatment addresses both the neurological and psychological dimensions rather than treating them as distinct problems.

Is low-dose naltrexone available as a treatment for long COVID?

LDN is an off-label use of naltrexone (approved at higher doses for addiction treatment). It's available by prescription in most countries, and physicians who specialize in long-COVID or ME/CFS do prescribe it. The evidence is in early-to-mid-stage trials, not yet at the level of a standard of care. A physician familiar with long-COVID management is the right person to discuss it with, not a general online search.

How do I know if someone has post-exertional malaise?

The hallmark is symptoms worsening after physical or mental exertion — disproportionately and delayed, not just being tired after activity. The person may feel okay during the exertion but crash hours or days later, substantially worse than their pre-activity baseline. If this pattern is present, standard graded exercise recommendations don't apply and can cause harm. Pacing and staying within the energy envelope takes priority.

Can someone fully recover from long-COVID neurological symptoms?

Research shows many people improve significantly over one to two years, though trajectories vary widely. Full recovery is documented and not uncommon; a reduced but stable functional baseline is also reported; for a smaller subset, symptoms persist longer. Earlier appropriate care — particularly avoiding the push-crash cycle — appears to improve long-term outcomes. The honest answer is that recovery is possible but not guaranteed, and timeline varies considerably by individual.